FSPM - FusionPharm, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue594.397308.398227.439
Cost of Revenue473.895222.723157.948
Gross Profit120.50285.67569.491
Operating Expenses
Research Development---
Selling General and Administrative130.65272.222384.417
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-10.148-186.547-314.927
Income from Continuing Operations
Total Other Income/Expenses Net-9.056-21.746-77.574
Earnings Before Interest and Taxes-19.204-208.293-392.501
Interest Expense22.87626.4919.881
Income Before Tax-42.08-234.784-402.382
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-42.08-234.784-303.802
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-42.08-234.784-402.382
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-42.08-234.784-402.382